TY  - JOUR
TI  - Omalizumab Treatment in Chronic Spontaneous Urticaria During Pregnancy: Report of A Case and Review of the Literature
AB  - Omalizumab is a safe and effective treatment option for chronic spontaneous urticaria (CSU). Although cohort studies in patients with asthma show no increased risk of congenital abnormalities, very little data exist in the literature regarding the use of omalizumab for CSU during pregnancy. Herein, the safe and successful use of omalizumab updosing in a pregnant woman with CSU along with a review of the published literature is presented.
AU  - AKTAŞ, Meryem
AU  - Salman, Andac
DO  - 10.21911/aai.599
PY  - 2021
JO  - Astım Allerji İmmünoloji
VL  - 19
IS  - 2
SN  - 1308-9234
SP  - 114
EP  - 117
DB  - TRDizin
UR  - http://search/yayin/detay/448630
ER  -